Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs ISHITA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA ISHITA DRUGS SAMRAT PHARMA/
ISHITA DRUGS
 
P/E (TTM) x 4,704.1 30.2 15,591.1% View Chart
P/BV x 1.6 2.1 77.1% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 SAMRAT PHARMA   ISHITA DRUGS
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
ISHITA DRUGS
Mar-23
SAMRAT PHARMA/
ISHITA DRUGS
5-Yr Chart
Click to enlarge
High Rs1,25080 1,571.3%   
Low Rs33240 840.5%   
Sales per share (Unadj.) Rs1,005.340.4 2,490.0%  
Earnings per share (Unadj.) Rs53.81.9 2,789.0%  
Cash flow per share (Unadj.) Rs55.92.4 2,364.2%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs204.330.7 666.1%  
Shares outstanding (eoy) m3.092.99 103.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.81.5 53.4%   
Avg P/E ratio x14.730.8 47.7%  
P/CF ratio (eoy) x14.125.2 56.2%  
Price / Book Value ratio x3.91.9 199.5%  
Dividend payout %1.90-   
Avg Mkt Cap Rs m2,444178 1,373.0%   
No. of employees `000NANA-   
Total wages/salary Rs m118 138.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,106121 2,573.3%  
Other income Rs m52 237.8%   
Total revenues Rs m3,111123 2,535.0%   
Gross profit Rs m2398 3,140.0%  
Depreciation Rs m61 498.4%   
Interest Rs m121 2,281.5%   
Profit before tax Rs m2258 2,892.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m592 2,920.8%   
Profit after tax Rs m1666 2,882.3%  
Gross profit margin %7.76.3 122.1%  
Effective tax rate %26.225.9 101.0%   
Net profit margin %5.44.8 111.9%  
BALANCE SHEET DATA
Current assets Rs m986102 968.9%   
Current liabilities Rs m52820 2,607.7%   
Net working cap to sales %14.867.6 21.9%  
Current ratio x1.95.0 37.2%  
Inventory Days Days8105 7.7%  
Debtors Days Days60254,431,599 0.0%  
Net fixed assets Rs m17512 1,425.6%   
Share capital Rs m3130 103.3%   
"Free" reserves Rs m60162 971.3%   
Net worth Rs m63192 688.4%   
Long term debt Rs m00-   
Total assets Rs m1,162114 1,018.2%  
Interest coverage x19.315.4 125.0%   
Debt to equity ratio x00-  
Sales to assets ratio x2.71.1 252.7%   
Return on assets %15.45.5 278.0%  
Return on equity %26.36.3 418.4%  
Return on capital %37.69.1 414.4%  
Exports to sales %4.10-   
Imports to sales %83.30-   
Exports (fob) Rs m127NA-   
Imports (cif) Rs m2,587NA-   
Fx inflow Rs m12717 724.9%   
Fx outflow Rs m2,5870 1,124,634.8%   
Net fx Rs m-2,46017 -14,251.9%   
CASH FLOW
From Operations Rs m-94-29 325.8%  
From Investments Rs m-306 -505.9%  
From Financial Activity Rs m9611 914.2%  
Net Cashflow Rs m-28-13 226.7%  

Share Holding

Indian Promoters % 48.6 49.4 98.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.4 50.6 101.5%  
Shareholders   8,065 5,283 152.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SAMRAT PHARMA vs ISHITA DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs ISHITA DRUGS Share Price Performance

Period SAMRAT PHARMA ISHITA DRUGS S&P BSE HEALTHCARE
1-Day -1.43% -0.37% 1.29%
1-Month -9.72% -12.07% -0.64%
1-Year -2.00% 44.84% 62.00%
3-Year CAGR 34.62% 30.99% 18.20%
5-Year CAGR 38.22% 34.79% 19.81%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the ISHITA DRUGS share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 48.6% stake in the company. In case of ISHITA DRUGS the stake stands at 49.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of ISHITA DRUGS.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 1.9%.

ISHITA DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of ISHITA DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.